Triple antithrombotic therapy for atrial fibrillation and coronary stents

被引:0
|
作者
Shmyr, Danielle [1 ]
Van der Merwe, Vanessa [2 ]
Yakiwchuk, Erin [2 ,3 ]
Barry, Arden [4 ,5 ]
Kosar, Lynette [6 ,7 ]
机构
[1] Saskatoon Hlth Reg, Saskatoon, SK, Canada
[2] Saskatoon Hlth Reg, Geriatr Evaluat & Management Program, Saskatoon, SK, Canada
[3] Saskatoon Hlth Reg, Pharm Dept, Saskatoon, SK, Canada
[4] Chilliwack Gen Hosp, Lower Mainland Pharm Serv, Chilliwack, BC, Canada
[5] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada
[6] Saskatoon Hlth Reg, RxFiles Acad Detailing Program, Saskatoon, SK, Canada
[7] Univ Saskatchewan, Coll Pharm, Saskatoon, SK, Canada
关键词
PROTON PUMP INHIBITORS; PERCUTANEOUS CORONARY; ANTIPLATELET THERAPY; FOCUSED UPDATE; CLOPIDOGREL; IMPLANTATION; MANAGEMENT; APIXABAN; DURATION; REGIMENS;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:375 / 381
页数:7
相关论文
共 50 条
  • [21] Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease
    Gremmel, Thomas
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (25): : 2480 - 2481
  • [22] Antithrombotic Therapy for Atrial Fibrillation and Coronary Disease Demystified
    Andrade, Jason G.
    Deyell, Marc W.
    Wong, Graham C.
    Macle, Laurent
    CANADIAN JOURNAL OF CARDIOLOGY, 2018, 34 (11) : 1426 - 1436
  • [23] Antithrombotic Therapy for acute Coronary Syndrome and Atrial Fibrillation
    Darius, Harald
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2020, 145 (14) : 978 - 986
  • [24] Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease
    Yasuda, Satoshi
    Kaikita, Koichi
    Akao, Masaharu
    Ako, Junya
    Matoba, Tetsuya
    Nakamura, Masato
    Miyauchi, Katsumi
    Hagiwara, Nobuhisa
    Kimura, Kazuo
    Hirayama, Atsushi
    Matsui, Kunihiko
    Ogawa, Hisao
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (12): : 1103 - 1113
  • [25] Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease
    Becker, Richard C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (12): : 1169 - 1170
  • [26] Duration of triple antithrombotic therapy and clinical outcomes after percutaneous coronary intervention in atrial fibrillation
    Sammut, Mark A.
    Conway, Dwayne
    Iqbal, Javaid
    Krishnamurthy, Arvindra
    Morgan, Kenneth P.
    Morris, Paul D.
    Richardson, James D.
    Rothman, Alexander M. K.
    Gunn, Julian P.
    Storey, Robert F.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2024, 22 (07) : 339 - 345
  • [27] Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention
    Yuichi Saito
    Yoshio Kobayashi
    Cardiovascular Intervention and Therapeutics, 2020, 35 : 44 - 51
  • [28] Triple antithrombotic therapy after coronary stenting in the elderly with atrial fibrillation: Necessary or too hazardous?
    Verheugt, Freek W. A.
    AMERICAN HEART JOURNAL, 2012, 163 (04) : 531 - 534
  • [29] Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention
    Saito, Yuichi
    Kobayashi, Yoshio
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2020, 35 (01) : 44 - 51
  • [30] Triple antithrombotic therapy benefits patients treated for atrial fibrillation
    Nature Clinical Practice Cardiovascular Medicine, 2008, 5 (6): : 299 - 299